More strong gains in US biotechs overnight (21/04 - Arrowhead +3%, Alnylam +4%, Gilead +2.5%) reaffirming the focus is turning from short term sentiment-driven fluctuations (profit-taking,panic-selling)back to fundamentals. Watch the IBB resume its powerful 12-month upward trajectory on its way to a multi-year bull market in biotechs. BLT will spike on positive news in this environment.
- Forums
- ASX - By Stock
- us biotechs rebound overnight
More strong gains in US biotechs overnight (21/04 - Arrowhead...
-
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)